<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27647922</article-id>
<article-id pub-id-type="pmc">5056085</article-id>
<article-id pub-id-type="publisher-id">201605740</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1605740113</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Neuroscience</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration</article-title>
<alt-title alt-title-type="short">4E-BP prevents mTOR-driven cortical mislamination</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Tiffany V.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hsieh</surname>
<given-names>Lawrence</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kimura</surname>
<given-names>Tomoki</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Malone</surname>
<given-names>Taylor J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bordey</surname>
<given-names>Angélique</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Neurosurgery, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06520;</aff>
<aff id="aff2"><sup>b</sup>Department of Cellular and Molecular Physiology, <institution>Yale University School of Medicine</institution>, New Haven, <addr-line>CT</addr-line> 06520</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence should be addressed. Email: <email>angelique.bordey@yale.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Nicholas Spitzer, University of California, San Diego, La Jolla, CA, and approved August 8, 2016 (received for review April 12, 2016)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: T.V.L. and A.B. designed research; T.V.L., L.H., and T.K. performed research; T.V.L., L.H., T.K., and T.J.M. analyzed data; and T.V.L. and A.B. wrote the paper.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>4</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>9</month>
<year>2016</year>
</pub-date>
<volume>113</volume>
<issue>40</issue>
<fpage>11330</fpage>
<lpage>11335</lpage>
<permissions></permissions>
<self-uri xlink:href="pnas.201605740.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>Increased mammalian target of rapamycin complex 1 (mTORC1) signaling is associated with many neurological and neurodevelopmental disorders, ranging from epilepsy to autism, that feature developmental defects in the organization of the cortex. Despite the fact that much research has focused on mTORC1-related disorders, the downstream effectors that produce these developmental defects are not well understood. To begin filling that void, this study looked at the role of one of the many cellular processes regulated by mTORC1, cap-dependent translation. Surprisingly, normalizing signaling through only one of mTORC1’s targets [eukaryotic initiation factor 4E-binding proteins (4E-BPs)] was able to block ectopic placement of cortical neurons, and mimicking mTORC1 signaling through 4E-BP alone was sufficient to induce neuron misplacement.</p>
</abstract>
<abstract>
<p>Hyperactive mammalian target of rapamycin complex 1 (mTORC1) is a shared molecular hallmark in several neurodevelopmental disorders characterized by abnormal brain cytoarchitecture. The mechanisms downstream of mTORC1 that are responsible for these defects remain unclear. We show that focally increasing mTORC1 activity during late corticogenesis leads to ectopic placement of upper-layer cortical neurons that does not require altered signaling in radial glia and is accompanied by changes in layer-specific molecular identity. Importantly, we found that decreasing cap-dependent translation by expressing a constitutively active mutant of the translational repressor eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) prevents neuronal misplacement and soma enlargement, while partially rescuing dendritic hypertrophy induced by hyperactive mTORC1. Furthermore, overactivation of translation alone through knockdown of 4E-BP2 was sufficient to induce neuronal misplacement. These data show that many aspects of abnormal brain cytoarchitecture can be prevented by manipulating a single intracellular process downstream of mTORC1, cap-dependent translation.</p>
</abstract>
<kwd-group>
<kwd>mTOR</kwd>
<kwd>autism</kwd>
<kwd>spine</kwd>
<kwd>dendrite</kwd>
<kwd>cortical development</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)<named-content content-type="funder-id">100000065</named-content></funding-source>
<award-id rid="sp1">R01 NS086329</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">McKnight Endowment Fund for Neuroscience<named-content content-type="funder-id">100000872</named-content></funding-source>
<award-id rid="sp2">none</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">Pfizer Patricia Goldman-Rakic fellowship</funding-source>
<award-id rid="sp3">none</award-id>
</award-group>
<award-group id="gs4">
<funding-source id="sp4">HHS | NIH | National Institute of General Medical Sciences (NIGMS)<named-content content-type="funder-id">100000057</named-content></funding-source>
<award-id rid="sp4">GM007324</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>